4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001464583-25-000005
CHIEF ACCOUNTING OFFICER sold 50,490 shares at an average $38.87 ($1,962,781)
- CHIEF ACCOUNTING OFFICER acquired 39,435 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Megna Michael R · CHIEF ACCOUNTING OFFICER
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-20 | Exercise or conversion : show line 1 in the form 10b5-1 | +791 | $15.50 | $12,261 | 38,892 | D |
| 2025-10-20 | Exercise or conversion : show line 2 in the form 10b5-1 | +6,195 | $12.97 | $80,349 | 45,087 | D |
| 2025-10-20 | Exercise or conversion : show line 3 in the form 10b5-1 | +9,831 | $11.10 | $109,124 | 54,918 | D |
| 2025-10-20 | Exercise or conversion : show line 4 in the form 10b5-1 | +9,831 | $11.97 | $117,677 | 64,749 | D |
| 2025-10-20 | Exercise or conversion : show line 5 in the form 10b5-1 | +12,787 | $10.76 | $137,588 | 77,536 | D |
| 2025-10-20 | Sale : show line 6 in the form 10b5-1 | −37,255 | $38.72 | $1,442,514 | 40,281 | D |
| 2025-10-20 | Sale : show line 7 in the form 10b5-1 | −13,235 | $39.31 | $520,268 | 27,046 | D |
| Open-market sales · 50,490 sh · avg $38.87 · $1,962,781 | ||||||
Table II: Derivative
5 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-20 | Exercise or conversion : show line 8 in the form 10b5-1 Share Option | −791 | 0 | D |
| 2025-10-20 | Exercise or conversion : show line 9 in the form 10b5-1 Share Option | −6,195 | 0 | D |
| 2025-10-20 | Exercise or conversion : show line 10 in the form 10b5-1 Share Option | −9,831 | 0 | D |
| 2025-10-20 | Exercise or conversion : show line 11 in the form 10b5-1 Share Option | −9,831 | 0 | D |
| 2025-10-20 | Exercise or conversion : show line 12 in the form 10b5-1 Share Option | −12,787 | 0 | D |
Loading xslF345X05/form4-10222025_091045.xml…